(Q52933092)
Statements
The pharmacokinetics and safety of ABT-751, a novel, orally bioavailable sulfonamide antimitotic agent: results of a phase 1 study. (English)
Kenneth R Hande
Anne Hagey
Jordan Berlin
Yingna Cai
Kysa Meek
Hiro Kobayashi
A Craig Lockhart
Diane Medina
Jeffrey Sosman
Gary B Gordon
Mace L Rothenberg
1 May 2006
12
9
2834-2840